Advanced Biomedical Research

The use of maternal C-reactive protein in the predicting of preterm labor and tocolytic therapy in preterm labor women

Authors

Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Levels of a number of some biomarkers have been associated with spontaneous preterm birth. This study was aimed to evaluate the relation between C-reactive protein (CRP) with preterm labor and response to tocolytic therapy.
Materials and Methods: Seventy five pregnant women with symptoms of preterm labor (cases) in compare with 75 term women (controls) were enrolled. Baseline data and CRP was recorded. So, cases were under treatment tocolysis with the use of magnesium sulfate, and then they were followed till delivery time to assess the response to the treatment.
Results: Sixteen patients with symptoms of preterm labor did not response to the treatment and delivered prematurely and 59 women response to tocolytic treatment and delivered at term. The curve constructed cut-off value for >3.6 (AUC, 0.683; SE, 0.041; P < 0.0001) for CRP, indicating a significant relationship with preterm labor. Also, there was significant relationship between CRP level with response to the treatment in cut-off >1.8 (AUC, 0.738; SE, 0.076; P = 0.001) for CRP.
Conclusions: Maternal concentrations of CRP can be used as appropriate biomarker for predicting preterm labor and response to tocolytic therapy in pregnant women.

Keywords

1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75-84.  Back to cited text no. 1
    
2. Roberts CL, Morris JM, Rickard KR, Giles WB, Simpson JM, Kotsiou G, et al. Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077]. BMC Pregnancy Childbirth 2011;11:19.  Back to cited text no. 2
    
3. Hoyert DL, Mathews TJ, Menacker F, Strobino DM, Guyer B. Annual summary of vital statistics: 2004. Pediatrics 2006;117:168-83.  Back to cited text no. 3
    
4. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: An updated systematic analysis for 2010 with time trends since 2000. Lancet 2012;379:2151-61.  Back to cited text no. 4
    
5. Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, de Bernis L. Lancet Neonatal Survival Steering Team. Evidence-based, cost-effective interventions: How many newborn babies can we save? Lancet 2005;365:977-88.  Back to cited text no. 5
    
6. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: A systematic review of maternal mortality and morbidity. Bull World Health Organ 2010;88:31-8.  Back to cited text no. 6
    
7. Green NS, Damus K, Simpson JL, Iams J, Reece EA, Hobel CJ, et al. Research agenda for preterm birth: Recommendations from the March of Dimes. Am J Obstet Gynecol 2005;193:626-35.  Back to cited text no. 7
    
8. Shahshahan Z, Hashemi M. Crown-rump length discordance in twins in the first trimester and its correlation with perinatal complications. J Res Med Sci 2011;16:1224-7.  Back to cited text no. 8
[PUBMED]  Medknow Journal  
9. Woodworth A, Moore J, G'Sell C, Verdoes A, Snyder JA, Morris L, et al. Diagnostic accuracy of cervicovaginal interleukin-6 and interleukin-6:Albumin ratio as markers of preterm delivery. Clin Chem 2007;53:1534-40.  Back to cited text no. 9
    
10. Lockwood CJ, Kuczynski E. Risk stratification and pathological mechanisms in preterm delivery. Paediatr Perinat Epidemiol 2001;15 Suppl 2:78-89.  Back to cited text no. 10
    
11. Mercer BM, Goldenberg RL, Das A, Moawad AH, Iams JD, Meis PJ, et al. The preterm prediction study: A clinical risk assessment system. Am J Obstet Gynecol 1996;174:1885-93.  Back to cited text no. 11
    
12. Offenbacher S, Lieff S, Boggess KA, Murtha AP, Madianos PN, Champagne CM, et al. Maternal periodontitis and prematurity. Part 1: Obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001;6:164-74.  Back to cited text no. 12
    
13. Kluft C, de Maat MP. Sensitive markers of inflammation make it possible tostudy the chronic process: The rise of interest in low levels of C-reactive protein. Vascul Pharmacol 2002;39:99-104.  Back to cited text no. 13
    
14. Mazor M, Kassis A, Horowitz S, Wiznitzer A, Kuperman O, Meril C, et al. Relationship between C-reactive protein levels and intraamniotic infection in women with pretermlabor. J Reprod Med 1993;38:799-803.  Back to cited text no. 14
    
15. Ghezzi F, Franchi M, Raio L, Di Naro E, Bossi G, D'Eril GV, et al. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. Am J Obstet Gynecol 2002;186:268-73.  Back to cited text no. 15
    
16. Sorokin Y, Romero R, Mele L, Wapner RJ, Iams JD, Dudley DJ, et al. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth<32 weeks and adverse neonatal outcomes. Am J Perinatol 2010;27:631-40.  Back to cited text no. 16
    
17. Kawagoe Y, Sameshima H, Ikenoue T, Yasuhi I, Kawarabayashi T. Magnesium sulfate as a second-line tocolytic agent for preterm labor: A randomized controlled trial in Kyushu island. J Pregnancy 2011;2011:6 pages, Article id 965060.  Back to cited text no. 17
    
18. Haas DM, Imperiale TF, Kirkpatrick PR, Klein RW, Zollinger TW, Golichowski AM. Tocolytic therapy: A meta-analysis and decision analysis. Obstet Gynecol 2009;113:585-94.  Back to cited text no. 18
    
19. Kam KY, Lamont RF. Developments in the pharmacotherapeutic management of spontaneous preterm labor. Expert Opin Pharmacother 2008;9:1153-68.  Back to cited text no. 19
    
20. Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med 2007;357:477-87.  Back to cited text no. 20
    
21. Tan TC, Devendra K, Tan LK, Tan HK. Tocolytic treatment for the management of preterm labour: A systematic review. Singapore Med J 2006;47:361-6.  Back to cited text no. 21
    
22. March of Dimes, Save the Children. Born Too Soon: The Global Action Report on Preterm Birth.Geneva: World Health Organization; 2012.  Back to cited text no. 22
    
23. Hadavi M, Alidalaki S, Abedininejad M, Akhavan S. Etiologies and contributing factors of perinatal mortality: A report from southeast of Iran. Taiwan J Obstet Gynecol 2011;50:145-8.  Back to cited text no. 23
    
24. Foulon W, Van Liedekerke D, Demanet C, Decatte L, Dewaele M, Naessens A. Markers of infection and their relationship to preterm delivery. Am J Perinatol 1995;12:208-11.  Back to cited text no. 24
    
25. Hvilsom GB, Thorsen P, Jeune B, Bakketeig LS. C-reactive protein: A serological marker for preterm delivery? Acta Obstet Gynecol Scand 2002;81:424-9.  Back to cited text no. 25
    
26. Vogel I, Grove J, Thorsen P, Moestrup SK, Uldbjerg N, Møller HJ. Preterm delivery predicted by soluble CD163 and CRP in women with symptoms of preterm delivery. BJOG 2005;112:737-42.  Back to cited text no. 26
    
27. Honest H, Forbes CA, Durée KH, Norman G, Duffy SB, Tsourapas A, et al. Screening to prevent spontaneouspreterm birth: Systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2009;13:1-627.  Back to cited text no. 27
Advanced Biomedical Research
Volume 2014, july
July 2014
Pages 1-5